Letter: Low FODMAP Therapy in Paediatric Irritable Bowel Syndrome: Balancing Efficacy, Expectancy and Safety
Alimentary Pharmacology & Therapeutics · 2026-10 · 64 (7) · 1021-1022
DOI: 10.1111/apt.70830 ↗At a glance
Leserbrief in Alimentary Pharmacology & Therapeutics, published online on 2026-06-29. Written by Yousef Hakimi and 1 co-authors. Institution: Monash Health, Clayton, Victoria, Australia. Cited 1 times so far (Crossref); 9 references. The full text is freely available in PubMed Central.
Abstract (original language)
Není k dispozici žádný abstrakt.
Authors and institutions
- Monash Health, Clayton, Victoria, Australia.
- Department of Paediatrics, Monash University, Clayton, Victoria, Australia.
- Centre for Innate Immunity and Infectious Disease, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
ORCID profiles: Yousef Hakimi
Cite
APA
Hakimi, Y., & Giles, E. (2026). Letter: Low FODMAP Therapy in Paediatric Irritable Bowel Syndrome: Balancing Efficacy, Expectancy and Safety. Alimentary Pharmacology & Therapeutics, 64(7), 1021-1022. https://doi.org/10.1111/apt.70830
Vancouver
Hakimi Y, Giles E. Letter: Low FODMAP Therapy in Paediatric Irritable Bowel Syndrome: Balancing Efficacy, Expectancy and Safety. Alimentary Pharmacology & Therapeutics. 2026;64(7):1021-1022. doi:10.1111/apt.70830
BibTeX
@article{Hakimi2026,
author = {Hakimi, Yousef and Giles, Edward},
title = {Letter: Low FODMAP Therapy in Paediatric Irritable Bowel Syndrome: Balancing Efficacy, Expectancy and Safety},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {64},
number = {7},
pages = {1021--1022},
doi = {10.1111/apt.70830}
}
EUVIMED